TransThera Sciences (Nanjing), Inc. - B - H Shares Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Wu Di, was filed 28 Jul 2026.
TransThera Sciences (Nanjing), Inc. - B - H Shares: what insiders have been doing
TransThera Sciences (Nanjing), Inc. - B - H Shares belongs to the Health Care sector. Filings by its managers are published through HKEX. The last twelve months, up to 1 November 2026, brought 2 filings signed by 2 insiders.
Only purchases show up on the open market, 2 purchases in all, filed by 2 insiders. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 2 senior executives among the declarants.
The last purchase on record was published on 28 July 2026, which is 104 days ago.
Across the 1,323 companies tracked on its exchange, the median is 4 filings; at 2 filings, this issuer sits below that mark. The full history, which starts in 2026, counts 2 purchases against no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleFinancial data
as of FY 2025FY ended December 2025 · cache
About TransThera Sciences (Nanjing), Inc. - B - H Shares
TransThera Sciences (Nanjing), Inc. is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It specializes in the research and commercialization of small molecule-based drugs.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
